Advertisement
Screener

AUXILIUM PHARMACEUTICALS INC Selling, General and Administrative Expense

AUXILIUM PHARMACEUTICALS INC Selling, General and Administrative Expense

AUXILIUM PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $72.49 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-10-30.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2014-10-30

  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-09-30 was $72.49M, a 15.42% increase year-over-year.
  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-06-30 was $69.20M, a 7.60% decline year-over-year.
  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-03-31 was $78.02M, a 76.07% increase year-over-year.
  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2013-12-31 was $68.18M, a 67.68% increase year-over-year.
  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2013 was $250.19M, a 34.85% increase from fiscal 2012.
  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2012 was $185.53M, a 3.14% increase from fiscal 2011.
  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2011 was $179.89M, a 9.24% increase from fiscal 2010.
  • AUXILIUM PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2010 was $164.68M, a 27.48% increase from fiscal 2009.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 12 month
2014-09-30$72.49M
10-Q · filed 2014-10-30
$141.70M
derived: sum of 2 quarters · filed 2014-10-30
$219.71M
10-Q · filed 2014-10-30
$287.89M
derived: sum of 4 quarters · filed 2014-10-30
2014-06-30$69.20M
10-Q · filed 2014-08-07
$147.22M
10-Q · filed 2014-08-07
$215.40M
derived: sum of 3 quarters · filed 2014-08-07
$278.21M
derived: sum of 4 quarters · filed 2014-10-30
2014-03-31$78.02M
10-Q · filed 2014-05-05
$146.19M
derived: sum of 2 quarters · filed 2014-05-05
$209.00M
derived: sum of 3 quarters · filed 2014-10-30
$283.90M
derived: sum of 4 quarters · filed 2014-10-30
2013-12-31$68.18M
10-K · filed 2014-02-28
$130.99M
derived: sum of 2 quarters · filed 2014-10-30
$205.88M
derived: sum of 3 quarters · filed 2014-10-30
$250.19M
10-K · filed 2014-02-28
2013-09-30$62.81M
10-Q · filed 2014-10-30
$137.70M
derived: sum of 2 quarters · filed 2014-10-30
$182.01M
10-Q · filed 2014-10-30
$222.67M
derived: sum of 4 quarters · filed 2014-10-30
2013-06-30$74.89M
10-Q · filed 2014-08-07
$119.20M
10-Q · filed 2014-08-07
$159.86M
derived: sum of 3 quarters · filed 2014-08-07
$215.21M
derived: sum of 4 quarters · filed 2014-08-07
2013-03-31$44.31M
10-Q · filed 2014-05-05
$84.97M
derived: sum of 2 quarters · filed 2014-05-05
$140.31M
derived: sum of 3 quarters · filed 2014-05-05
$182.90M
derived: sum of 4 quarters · filed 2014-05-05
2012-12-31$40.66M
10-K · filed 2014-02-28
$96.00M
derived: sum of 2 quarters · filed 2014-02-28
$138.59M
derived: sum of 3 quarters · filed 2014-02-28
$185.53M
10-K · filed 2014-02-28
2012-09-30$55.34M
10-K · filed 2014-02-28
$97.93M
derived: sum of 2 quarters · filed 2014-02-28
$144.87M
10-Q · filed 2013-11-06
$194.97M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30$42.59M
10-K · filed 2014-02-28
$89.53M
10-Q · filed 2013-08-01
$139.63M
derived: sum of 3 quarters · filed 2014-02-28
$182.89M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31$46.95M
10-K · filed 2014-02-28
$97.05M
derived: sum of 2 quarters · filed 2014-02-28
$140.31M
derived: sum of 3 quarters · filed 2014-02-28
$183.68M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$50.10M
10-K · filed 2013-02-26
$93.36M
derived: sum of 2 quarters · filed 2013-02-26
$136.73M
derived: sum of 3 quarters · filed 2013-02-26
$179.89M
10-K · filed 2014-02-28
2011-09-30$43.26M
10-K · filed 2013-02-26
$86.63M
derived: sum of 2 quarters · filed 2013-02-26
$129.79M
10-Q · filed 2012-11-08
$176.80M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30$43.37M
10-K · filed 2013-02-26
$86.53M
10-Q · filed 2012-07-31
$133.53M
derived: sum of 3 quarters · filed 2013-02-26
$173.87M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31$43.16M
10-K · filed 2013-02-26
$90.17M
derived: sum of 2 quarters · filed 2013-02-26
$130.50M
derived: sum of 3 quarters · filed 2013-02-26
$171.73M
derived: sum of 4 quarters · filed 2013-02-26
2010-12-31$47.01M
10-K · filed 2012-02-29
$87.34M
derived: sum of 2 quarters · filed 2012-02-29
$128.57M
derived: sum of 3 quarters · filed 2012-02-29
$164.68M
10-K · filed 2013-02-26
2010-09-30$40.34M
10-K · filed 2012-02-29
$81.56M
derived: sum of 2 quarters · filed 2012-02-29
$117.67M
10-Q · filed 2011-11-09
$156.38M
derived: sum of 4 quarters · filed 2012-02-29
2010-06-30$41.23M
10-K · filed 2012-02-29
$77.33M
10-Q · filed 2011-08-02
$116.04M
derived: sum of 3 quarters · filed 2012-02-29
$150.73M
derived: sum of 4 quarters · filed 2012-02-29
2010-03-31$36.10M
10-K · filed 2012-02-29
$74.81M
derived: sum of 2 quarters · filed 2012-02-29
$109.50M
derived: sum of 3 quarters · filed 2012-02-29
$138.88M
derived: sum of 4 quarters · filed 2012-02-29
2009-12-31$38.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$73.39M
derived: sum of 2 quarters · filed 2012-02-29
$102.78M
derived: sum of 3 quarters · filed 2012-02-29
$129.18M
10-K · filed 2012-02-29
2009-09-30$34.69M
10-Q · filed 2010-11-08
$64.07M
derived: sum of 2 quarters · filed 2010-11-08
$90.47M
10-Q · filed 2010-11-08
2009-06-30$29.38M
10-Q · filed 2010-08-06
$55.78M
10-Q · filed 2010-08-06
2008-12-31$89.48M
10-K · filed 2011-03-01